Engineered immune cells with 'Sleep Switch' tested for tough leukemia
NCT ID NCT03016377
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times
Summary
This study tests a new treatment for people with a type of leukemia that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to better find and kill leukemia cells. A special safety switch is added to these cells so they can be turned off if dangerous side effects occur. The main goal is to see if this approach is safe and tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.